Crucial Guide: How Can Mail Order Bride Work?

18/Sep/2018

Crucial Guide: How Can Mail Order Bride Work? This marriage platform has enabled Western guys to explore outside their nations for good and smart women that are desperate to keep their nations. From Russia to Philippines, there are countless women who would like to explore the possibility and look for males outside their geographic location. … Continue reading "Crucial Guide: How Can Mail Order Bride Work?"....

Batu Biologics Identifies Gene Types Associated with Response to ValloVax

14/Sep/2018

Preliminary Evaluation of Over 100 Patients Treated with Cancer Blood Vessel Targeting Immunotherapy Reveals Gene Association with Clinical Response....

Batu Biologics Files Patent on Patient Selection for Right to Try Law

14/Sep/2018

Clinical Stage Immunotherapy Company Creates System of Selecting Patients for Optimized Outcome under President Donald Trump’s Right to Try Law....

Batu Biologics Recruits Nobel Prize Winner Bruce Beutler

12/Sep/2018

Nobel Prize Winning Immunologist Joins Batu Biologics in Quest to “Starve the Tumor” Clinical Stage Immuno-Oncology Company Recruits Pioneer of Innate Immunity to Scientific Advisory Board Batu Biologics announced today the appointment of Nobel Prize winner Dr. Bruce Beutler to the Company’s Scientific Advisory Board. Read the full article at businesswire.com....

Batu Biologics Releases Shareholder Letter

31/Sep/2018

Company discusses the clinical progress of the ValloVax Therapeutic Vaccine at the CHIPSA Hospital Samuel C. Wagner, President and CEO of Batu Biologics, has issued the following letter to the shareholders of the Company, providing a comprehensive update on the clinical progress of the ValloVax immune therapy: Read the full article at businesswire.com....

Dr. Francesco Marincola Appointed as Chairman of Batu Biologics Clinical Advisory Board

24/Sep/2018

Pioneer of Tumor Immunotherapy Dr. Francesco Marincola Appointed as Chairman of Batu Biologics Clinical Advisory Board Former President of the Society for Immunotherapy of Cancer to Assist Company in Advancement of its Anti-Angiogenesis Immunotherapy Product ValloVax Batu Biologics, committed to advancement of its clinical stage cancer immunotherapeutic, ValloVax™, announced today the appointment of Dr. Francesco … Continue reading "Dr. Francesco Marincola Appointed as Chairman of Batu Biologics Clinical Advisory Board"....

Batu Biologics CEO to Moderate Congressional Immunotherapy Symposium

16/Sep/2018

Batu Biologics Chief Executive Officer Samuel Wagner to Moderate Congressional Immunotherapy Symposium Congressional Candidate to Hear Concerns of Industry Leaders in Health Care Innovations Batu Biologics, a clinical stage immunotherapy company, announced today its Chief Executive Officer, Samuel Wagner, was chosen to moderate an internationally renowned panel of biotechnology companies focusing on immunotherapy. Read the … Continue reading "Batu Biologics CEO to Moderate Congressional Immunotherapy Symposium"....

Batu Biologics CEO Selected for Lyfebulb Oncology Award

2/Sep/2018

Batu Biologics CEO Selected as Finalist for Lyfebulb-Helsinn Innovation Summit and Award For Oncology Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology Lyfebulb, a patient empowerment platform that connects patients, industry and investors to support user-driven innovation in chronic diseases, and Helsinn, today announced the names of … Continue reading "Batu Biologics CEO Selected for Lyfebulb Oncology Award"....

Batu Biologics Raises $1.3 Million in Equity Crowdfunding

25/Sep/2017

Batu Biologics Successfully Completes $1.3 Million #Starvethetumor Equity Crowdfunding Campaign Company Intends to Aggressively Pursue Clinical Development of Angiogenesis Targeting Immunotherapy Product ValloVax Batu Biologics, an immuno-oncology Company dedicated to the development of its clinical stage tumor-angiogenesis targeting immunotherapy, ValloVax™, announced today the successful closure of a regulation 506(c) equity crowdfunding offering bringing in $1.3 … Continue reading "Batu Biologics Raises $1.3 Million in Equity Crowdfunding"....

Batu Biologics Receives FDA IND Clearance

7/Sep/2017

Batu Biologics Receives FDA Clearance for First Multi-Pronged Immunotherapy Targeting the Blood Vessels that Feed Cancer Company’s First-in-Class Drug, ValloVax, Acts by Educating Immune System to Starve Tumors Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, has received an Investigational New Drug (IND) approval from the U.S. … Continue reading "Batu Biologics Receives FDA IND Clearance"....

1 2 3 6